The political economy of the global pharmaceutical industry

Author:

Hira Anil

Abstract

PurposeThe majority of the world's population has limited access to needed medicines. The purpose of this paper is to explain why certain characteristics of the global pharmaceutical market have not served a large majority of potential consumers in the developing world.Design/methodology/approachThrough a political economy analysis of evolutionary and regulatory aspects of both supply and demand conditions for global pharmaceuticals, it can be understood why most of the world's poor have limited access to basic medicines. The paper then turns to what avenues are available for improving access to medicines. An analysis of the chief proposed solutions, namely: pooled demand and relaxation of intellectual property rights, reveals their inadequacies. A third emerging avenue, the growing production of pharmaceuticals in the south, is examined through case studies of leading producers including India, China, and South America.FindingsWhile each of the three options offers potential benefits, none is adequate to solve the problem – a new, perhaps combinatorial, approach will be needed to ensure that a wider global market for pharmaceuticals can be created.Originality/valueThe paper offers insights into the political economy of the global pharmaceutical industry.

Publisher

Emerald

Subject

Political Science and International Relations,Economics and Econometrics,Development

Reference48 articles.

1. AccountAbility (2004), Business and Economic Development: Pharmaceutical Sector Report, AccountAbility, London, December, p. 43.

2. Agrawal, M. (1999), Global Competitiveness in the Pharmaceutical Industry: The Effect of National Regulatory, Economic, and Market Features, Pharmaceutical Products Press, New York, NY.

3. Anil, H. (2007), An East Asian Model for Latin America, Ashgate, Burlington, VT.

4. Attaran, A. (2004), “How do patents and economic policies affect access to essential medicines in developing countries? Poverty, not patent policies, more often inhibits access to essential medicines in the developing world”, Health Affairs, Vol. 23 No. 3, pp. 155‐66.

5. Barrett, M.P. (2006), “The rise and fall of sleeping sickness”, The Lancet, Vol. 367, pp. 1377‐8.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Interconnectedness, Complexity and Dynamics in Supply;Research for Development;2024

2. Beyond the crisis: transitioning to a better world?;Cultural Studies;2021-03-15

3. Unstable pharmaceutical values: the grey political economy of drug circulation in Cambodia;BioSocieties;2021-01-29

4. A policy-making strategy to forecast outcomes of drug development in Indonesia;International Journal of Health Governance;2020-03-26

5. Strategic issues in pharmaceutical supply chains: a review;International Journal of Pharmaceutical and Healthcare Marketing;2016-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3